Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Apellis Pharmaceuticals sell collins

Start price
€34.98
31.03.26 / 0%
Target price
-
31.03.27
Performance (%)
0.21%
Price
€35.05
13.05.26
Summary
This prediction is currently active. The SELL prediction by collins for Apellis Pharmaceuticals is nearly unchanged. This prediction currently runs until 31.03.27. The prediction end date can be changed by collins at any time. This prediction was marked as speculative and is excluded from collins's performance statistics.
Performance without dividends (%)
Name 1w 1m
Apellis Pharmaceuticals - -
iShares Core DAX® 0,44 % 5,64 %
iShares Nasdaq 100 1,06 % 0,28 %
iShares Nikkei 225® 1,77 % 0,41 %
iShares S&P 500 0,37 % 1,92 %

Comments by collins for this prediction

In the thread Apellis Pharmaceuticals diskutieren

Sell Apellis Pharmaceuticals